they could come in short even at 30 million and if you annualise...

they could come in short even at 30 million and if you annualise that with zero growth it’s 120 million. The point I made was to another poster basing a valuation primarily off 2020 fy results and not looking forward and forecasting additional growth. Now if you consider bulk of the B2B sales are growing through UK, Europe, Ireland imagine what happens when they hit other regions. I’m sure many thought 11 million in a month was not possible before either but what happens when businesses, small businesses etc are preparing to come out of lockdown. They ramp up their supplies of zoono microbe shield because they know they are going to need it. As word of mouth spread more and more businesses come into the mix. So if they don’t do 40 million this quarter it won’t matter as it won’t be far off.